Cordlife Group (SG:P8A) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Cordlife Group Limited has been directed by the Ministry of Health to halt its cord blood and human tissue services due to non-compliance with healthcare regulations. The company is actively working on rectification measures, establishing an oversight committee and a Medical and Technical Advisory Board to address the issues. They have also partnered with Shandong Qilu Stemcell Engineering to assist in improving their operations during this period.
For further insights into SG:P8A stock, check out TipRanks’ Stock Analysis page.
